Drug
arzoxifene
arzoxifene is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_2
2
33%
Ph phase_3
3
50%
Ph phase_4
1
17%
Phase Distribution
0
Early Stage
2
Mid Stage
4
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (33.3%)
Phase 33 (50.0%)
Phase 41 (16.7%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
NCT00005879
completedphase_2
A Study of Arzoxifene to Treat Korean Women With Osteoporosis
NCT00767299
completedphase_3
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer
NCT00088010
completedphase_3
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
NCT00383422
completedphase_4
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
NCT00190697
Clinical Trials (6)
Showing 6 of 6 trials
NCT00005879Phase 2
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
NCT00767299Phase 2
A Study of Arzoxifene to Treat Korean Women With Osteoporosis
NCT00088010Phase 3
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer
NCT00383422Phase 3
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
NCT00190697Phase 4
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
NCT00085956Phase 3
Effects of Arzoxifene on Bone Mass and the Uterus
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6